Chinese Drug Co. Says Sanctions In Valsartan MDL Too Harsh
By George Woolston · August 5, 2024, 7:35 PM EDT
Chinese drug firm Zhejiang Huahai Pharmaceutical Co. Ltd. told a New Jersey federal court Friday that sanctions authorizing two adverse jury instructions in multidistrict litigation over generic drugs contaminated with carcinogens...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login